Timothy Labranche

Timothy Labranche

Blueprint Medicines - / United States
Others
AD Scientific Index ID: 4979943
person_outline Timothy Labranche's MOST POPULAR ARTICLES
1-) Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550) K Ghoreschi, MI Jesson, X Li, JL Lee, S Ghosh, JW Alsup, JD Warner, ... The Journal of Immunology 186 (7), 4234-4243, 2011 6372011
2-) A precision therapy against cancers driven by KIT/PDGFRA mutations EK Evans, AK Gardino, JL Kim, BL Hodous, A Shutes, A Davis, XJ Zhu, ... Science translational medicine 9 (414), eaao1690, 2017 1582017
3-) JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production TP LaBranche, MI Jesson, ZA Radi, CE Storer, JA Guzova, SL Bonar, ... Arthritis & Rheumatism 64 (11), 3531-3542, 2012 1332012
4-) Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxiaJF Nabhan, KM Wood, VP Rao, J Morin, S Bhamidipaty, TP LaBranche, ...Scientific reports 6 (1), 20019, 20161492016
5-) Th17 cells can provide B cell help in autoantibody induced arthritisCL Hickman-Brecks, JL Racz, DM Meyer, TP LaBranche, PM AllenJournal of autoimmunity 36 (1), 65-75, 2011822011